Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Intravacc
Intravacc
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Intravacc and Primrose Bio partner to enhance conjugate vaccine development
The expansion of the PeliCRM197 franchise creates a full-service solution for early-stage customers and partners
Drug Delivery
Intravaac shares publication of OMV-based intranasal vaccine review
The CDMO has shared the publication in Current Opinion in Immunology regarding the efficacy its OMV-based vaccines, administered intranasally
Drug Delivery
CEPI and Intravacc to develop Betacoronavirus vaccine
CEPI will provide seed funding of up to US$4.8 million to Intravacc - a world leader in translational research and development of preventive and therapeutic vaccines
Manufacturing
Intravacc awarded $14.6m toward gonorrhoea vaccine
Gonorrhoea is on the WHO high-priority list of antimicrobial resistant bacteria
Drug Delivery
Intravacc to begin clinical trials for nasal COVID vaccine
The design of the vaccine is aimed to provide broad protection, harnessing both arms of the immune system
Design & Build
Intravacc leads consortium on Dutch multi-purpose vaccine plant
It has also built a pilot production plant at Utrecht Science Park over the past 24 months
Finance
Intravacc and Cristal Therapeutics announce vaccine collaboration
As part of the agreement, Intravacc will provide access to its detoxified LPS technology to enhance immune activation
Subscribe now